170 related articles for article (PubMed ID: 3350230)
41. Amelioration of cisplatin-induced nephrotoxicity by the diuretic acetazolamide in F344 rats.
Osman NM; Copley MP; Litterst CL
Cancer Treat Rep; 1984; 68(7-8):999-1004. PubMed ID: 6540145
[TBL] [Abstract][Full Text] [Related]
42. Nephrotoxicity of cisplatin, carboplatin and transplatin. A comparative in vitro study.
Hannemann J; Baumann K
Arch Toxicol; 1990; 64(5):393-400. PubMed ID: 2169720
[TBL] [Abstract][Full Text] [Related]
43. Relationship between cisplatin or nedaplatin-induced nephrotoxicity and renal accumulation.
Kawai Y; Taniuchi S; Okahara S; Nakamura M; Gemba M
Biol Pharm Bull; 2005 Aug; 28(8):1385-8. PubMed ID: 16079479
[TBL] [Abstract][Full Text] [Related]
44. Disparity in actions of rosiglitazone against cisplatin-induced nephrotoxicity in female Sprague-Dawley rats.
Kumar P; Prashanth KS; Gaikwad AB; Vij M; Barua CC; Bezbaruah B
Environ Toxicol Pharmacol; 2013 Nov; 36(3):883-90. PubMed ID: 24001946
[TBL] [Abstract][Full Text] [Related]
45. Effects of disopyramide and verapamil on renal disposition and nephrotoxicity of cisplatin in rats.
Hanada K; Odaka K; Kudo A; Ogata H
Pharm Res; 1999 Oct; 16(10):1589-95. PubMed ID: 10554102
[TBL] [Abstract][Full Text] [Related]
46. Naringenin attenuates cisplatin nephrotoxicity in rats.
Badary OA; Abdel-Maksoud S; Ahmed WA; Owieda GH
Life Sci; 2005 Mar; 76(18):2125-35. PubMed ID: 15826879
[TBL] [Abstract][Full Text] [Related]
47. Interaction of D,L- and D-tetraplatin with hyperthermia in vitro and in vivo.
Epelbaum R; Teicher BA; Holden SA; Ara G; Varshney A; Herman TS
Eur J Cancer; 1992; 28A(4-5):794-800. PubMed ID: 1524897
[TBL] [Abstract][Full Text] [Related]
48. Vestibular morphological analysis of the effects of cisplatin vs. platinum analogs, CBDCA (JM-8) and CHIP (JM-9).
Schweitzer VG; Rarey KE; Dolan DF; Abrams GE; Sheridan C
Laryngoscope; 1986 Sep; 96(9 Pt 1):959-74. PubMed ID: 3528727
[TBL] [Abstract][Full Text] [Related]
49. Effects of the diuretics mannitol or acetazolamide on nephrotoxicity and physiological disposition of cisplatin in rats.
Osman NM; Copley MP; Litterst CL
Cancer Chemother Pharmacol; 1984; 13(1):58-62. PubMed ID: 6428763
[TBL] [Abstract][Full Text] [Related]
50. Beneficial effect of acetylcysteine on cisplatin nephrotoxicity in rats.
Appenroth D; Winnefeld K; Schröter H; Rost M
J Appl Toxicol; 1993; 13(3):189-92. PubMed ID: 8326088
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of the nephrotoxicity of iproplatin (CHIP) in comparison to cisplatin by the measurement of urinary enzymes.
Pendyala L; Madajewicz S; Lele SB; Arbuck SG; Creaven PJ
Cancer Chemother Pharmacol; 1985; 15(3):203-7. PubMed ID: 4053265
[TBL] [Abstract][Full Text] [Related]
52. Circumvention of acquired tetraplatin resistance in a human ovarian carcinoma cell line by a novel trans platinum complex, JM335 [trans ammine (cyclohexylamine) dichloro dihydroxo platinum (IV)].
Mellish KJ; Barnard CF; Kelland LR; Harrap KR
Int J Cancer; 1994 Oct; 59(1):65-70. PubMed ID: 7927906
[TBL] [Abstract][Full Text] [Related]
53. Possible mechanism of PNS protection against cisplatin-induced nephrotoxicity in rat models.
Liu X; Huang Z; Zou X; Yang Y; Qiu Y; Wen Y
Toxicol Mech Methods; 2015; 25(5):347-54. PubMed ID: 25598344
[TBL] [Abstract][Full Text] [Related]
54. In vitro biotransformations of tetrachloro(d,l-trans)-1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) in rat plasma.
Chaney SG; Wyrick S; Till GK
Cancer Res; 1990 Aug; 50(15):4539-45. PubMed ID: 2196115
[TBL] [Abstract][Full Text] [Related]
55. Cisplatin-induced loss of kidney copper and nephrotoxicity is ameliorated by single dose diethyldithiocarbamate, but not mesna.
DeWoskin RS; Riviere JE
Toxicol Appl Pharmacol; 1992 Feb; 112(2):182-9. PubMed ID: 1311464
[TBL] [Abstract][Full Text] [Related]
56. Time course of the change and amelioration of nedaplatin-induced nephrotoxicity in rats.
Uehara T; Tsuchiya N; Masuda A; Torii M; Nakamura M; Yamate J; Maruyama T
J Appl Toxicol; 2008 Apr; 28(3):388-98. PubMed ID: 17685399
[TBL] [Abstract][Full Text] [Related]
57. Comparative nephrotoxicity of a novel platinum compound, cisplatin, and carboplatin in male Wistar rats.
Wolfgang GH; Dominick MA; Walsh KM; Hoeschele JD; Pegg DG
Fundam Appl Toxicol; 1994 Jan; 22(1):73-9. PubMed ID: 8125216
[TBL] [Abstract][Full Text] [Related]
58. Sensitivity of urinary enzymes as indicators of renal toxicity of the anticancer drug cis-platin.
Litterst C; Smith JH; Smith MA; Uozumi J; Copley M
Uremia Invest; 1985-1986; 9(2):111-7. PubMed ID: 2876540
[TBL] [Abstract][Full Text] [Related]
59. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of cis-platinum nephrotoxicity by diethyldithiocarbamate rescue in a rat model.
Borch RF; Pleasants ME
Proc Natl Acad Sci U S A; 1979 Dec; 76(12):6611-4. PubMed ID: 230514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
